동남권원자력의학원 의료진소개

유도솔

유도솔

전문진료분야

두경부암, 폐암, 식도암, 부인암, 피부암

학력사항

고려대학교 의학 학사 / 서울대학교 임상의과학과 석사

경력

유도솔 경력사항으로 연도별 경력내용 제공
2011년 - 2012년 서울대학교병원 수련의
2012년 - 2016년 서울대학교병원 방사선종양학과 전공의
2015년 - 2015년 미국 Memorial Sloan Kattering 암센터 단기연수
2016년 - 2017년 인천시 옹진군 대청면보건지소 공중보건의
2017년 - 2019년 강릉시 강동면보건지소장
2019년 - 현재 동남권원자력의학원 방사선종양학과 과장

주요활동

  • 대한두경부학회
  • 미국방사선종양학회
  • 대한암학회
  • 대한방사선종양학회 정회원

연구업적

  • Stereotactic body radiotherapy for centrally located primary non-small cell lung cancer: a meta-analysis. Yu T, Shin IS, Yoon WS, Rim CH. Clin Lung Cancer. 2019 Mar doi: 10.1016/j.clic.2019.02.023. [Epub ahead of print]
  • Early closure of a Phase I clinical trial of SABR in early-stage glottis cancer. Kang BH, Yu T, Kim J, Park JM, Kim JI, Chung EJ, Kwon SK, Kim JH, Wu HG. Int J Radiat Oncol Biol Phys. 2019 March 19 doi: 10.1016/j.ijrobp.2019.03.011. [Epub ahead of print]
  • Study design and early result of a phase I study of SABR for early-stage glottic cancer. Yu T, Wee Cw, Choi N, Wu HG, Kang HC, Park JM, Kim JI, Kim JH, Kwon TK, Chung EJ. Laryngoscope. 2018 Nov;128(11):2560-2565.
  • Does fluid collection impact radiotherapy outcomes after wide excision of lower extremity soft tissue sarcoma? Choi N, Kim JY, Yu T, Kang HC, Kim HS, Kim HJ, Kim I. Jpn J Clin Oncol. 2017 Nov48(2):1-7.
  • Radiosensitizing effect of lapatinib in human epidermal growth factor receptor 2-positive breast cancer cells. Yu T, Cho BJ, Choi EJ, Park JM, Kim DH, Kim IA. Oncotarget. 2016 Oct 12:7(48):79089-79100.
  • Objective Measurement of Cosmetic Outcomes of Breast Conserving Therapy Using BCCT.core. Yu T, Eom KY, Jang NY, Kim KS, Koo TR, Kwon J, Kim BH, Kang E, Kim SW, Kim JS, Kim IA. Cancer Res Treat. 2016 Apr 22;48(2):491-8.
  • Pattern of care of anaplastic oligodendroglioma and oligoastrocytoma in a Korean population: the Korean radiation oncology group study 13-12. Yu T, Kang HC, Lim do H, Kim IH, Chung WK, Suh CO, Choi BO, Cho KH, Cho JH, Kim JH, Park CK, Hong YK, Kim IA. J Neurooncol. 2015 Feb;121(3):531-9.
  • A multicenter study of anaplastic oligodendroglioma: the Korean Radiation Oncology Group Study 13-12. Kang HC, Yu T, Lim DH, Kim IH, Chung WK, Suh CO, Choi BO, Cho WH,Cho JH, Kim JH, Nam DH, Park CK, Hong YK, Kim IA. J Neurooncol. 2015 Oct:125(1):207-15.
  • Dose-volumetric parameters for predicting hypothyroidism after radiotherapy for head and neck cancer. Kim MY, Yu T, Wu HG. Jpn J Clin Oncol. 2014 Apr;44(4):331-7.
  • Fluorodeoxyglucose positron-emission tomography ratio in non-small cell lung cancer patients treated with definitive radiotherapy. Kang HC, Wu HG, Yu T, Kim HJ, Paeng JC. Radiat Oncol J. 2013 Sep;31(3):111-7.
  • Radiosensitizing effect of Lapatinib in HER2-positive breast cancer cells (Master’s thesis). Yu T. (2015). Available from http://library.snu.ac.kr/
  • Outcome analysis in patients with uterine sarcoma. Yu T, Kim HJ, Wu HG, Ha SW, Song YS, Park NH, Kim JW. Radiat Oncol J. 2015 Mar;33(1).